InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Sarepta Therapeutics, Inc.

SRPT Clue Score46
United States Fiscal year ends December CIK 0000873303
$17.85 -1.98% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $17.85 −80.45% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue5.4Operating income−266.7Net income−267.3Fiscal year 2017Revenue154.6 +2,751.6%Operating income−171.6Net income−50.7Fiscal year 2018Revenue301.0 +94.7%Operating income−343.6Net income−361.9Fiscal year 2019Revenue380.8 +26.5%Operating income−705.6Net income−715.1Fiscal year 2020Revenue455.9 +19.7%Operating income−564.2Net income−554.1EPS, diluted−7.11Fiscal year 2021Revenue612.4 +34.3%Operating income−459.7Net income−418.8EPS, diluted−5.15Fiscal year 2022Revenue843.8 +37.8%Operating income−536.2Net income−703.5EPS, diluted−8.03Fiscal year 2023Revenue1,144.9 +35.7%Operating income−267.8Net income−536.0EPS, diluted−5.80Fiscal year 2024Revenue1,788.0 +56.2%Operating income218.1Net income235.2EPS, diluted2.34Fiscal year 2025Revenue1,864.3 +4.3%Operating income−699.8Net income−713.4 −403.3%EPS, diluted−7.13 −404.7%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 5.4 154.6 301.0 380.8 455.9 612.4 843.8 1,144.9 1,788.0 1,864.3
Growth +2,751.6% +94.7% +26.5% +19.7% +34.3% +37.8% +35.7% +56.2% +4.3%
Operating income −266.7 −171.6 −343.6 −705.6 −564.2 −459.7 −536.2 −267.8 218.1 −699.8
Net income −267.3 −50.7 −361.9 −715.1 −554.1 −418.8 −703.5 −536.0 235.2 −713.4
Growth −403.3%
EPS, diluted n/a n/a n/a n/a −7.11 −5.15 −8.03 −5.80 2.34 −7.13
Growth −404.7%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−4,920.3%Net margin−4,930.2%Free cash flow margin−4,633.1%Fiscal year 2017Operating margin−111.0%Net margin−32.8%Free cash flow margin−157.8%Fiscal year 2018Operating margin−114.1%Net margin−120.2%Free cash flow margin−149.4%Fiscal year 2019Operating margin−185.3%Net margin−187.8%Free cash flow margin−135.5%Fiscal year 2020Operating margin−123.8%Net margin−121.6%Free cash flow margin5.5%Fiscal year 2021Operating margin−75.1%Net margin−68.4%Free cash flow margin−78.7%Fiscal year 2022Operating margin−63.5%Net margin−83.4%Free cash flow margin−42.2%Fiscal year 2023Operating margin−23.4%Net margin−46.8%Free cash flow margin−50.4%Fiscal year 2024Operating margin12.2%Net margin13.2%Free cash flow margin−19.2%Fiscal year 2025Operating margin−37.5%Net margin−38.3%Free cash flow margin−16.5%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −4,920.3% −111.0% −114.1% −185.3% −123.8% −75.1% −63.5% −23.4% 12.2% −37.5%
Net margin −4,930.2% −32.8% −120.2% −187.8% −121.6% −68.4% −83.4% −46.8% 13.2% −38.3%
Free cash flow margin −4,633.1% −157.8% −149.4% −135.5% 5.5% −78.7% −42.2% −50.4% −19.2% −16.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−245.8Capital expenditure−5.3Free cash flow−251.2Fiscal year 2017Operating cash flow−232.0Capital expenditure−12.0Free cash flow−244.0Fiscal year 2018Operating cash flow−388.7Capital expenditure−61.2Free cash flow−449.8Fiscal year 2019Operating cash flow−456.5Capital expenditure−59.6Free cash flow−516.1Fiscal year 2020Operating cash flow107.5Capital expenditure−82.2Free cash flow25.3Fiscal year 2021Operating cash flow−443.2Capital expenditure−38.5Free cash flow−481.7 −2,006.5%Fiscal year 2022Operating cash flow−325.3Capital expenditure−30.8Free cash flow−356.2Fiscal year 2023Operating cash flow−501.0Capital expenditure−76.1Free cash flow−577.1Buybacks0.0Fiscal year 2024Operating cash flow−205.8Capital expenditure−137.0Free cash flow−342.7Buybacks0.0Fiscal year 2025Operating cash flow−205.5Capital expenditure−102.0Free cash flow−307.5Buybacks−25.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −245.8 −232.0 −388.7 −456.5 107.5 −443.2 −325.3 −501.0 −205.8 −205.5
Capital expenditure −5.3 −12.0 −61.2 −59.6 −82.2 −38.5 −30.8 −76.1 −137.0 −102.0
Free cash flow −251.2 −244.0 −449.8 −516.1 25.3 −481.7 −356.2 −577.1 −342.7 −307.5
Growth −2,006.5%
Buybacks n/a n/a n/a n/a n/a n/a n/a 0.0 0.0 −25.0

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash122.4Total debt17.7Net cash (debt)104.8Shareholders’ equity336.7Debt to equity0.05Fiscal year 2017Cash599.7Total debt431.1Net cash (debt)168.6Shareholders’ equity789.2Debt to equity0.55Fiscal year 2018Cash370.8Total debt420.6Net cash (debt)−49.7Shareholders’ equity1,032.3Debt to equity0.41Fiscal year 2019Cash835.1Shareholders’ equity818.2Fiscal year 2020Cash1,502.6Shareholders’ equity761.8Fiscal year 2021Cash2,115.9Total debt563.7Net cash (debt)1,552.2Shareholders’ equity928.0Debt to equity0.61Fiscal year 2022Cash966.8Total debt1,544.3Net cash (debt)−577.5Shareholders’ equity385.0Debt to equity4.01Fiscal year 2023Cash428.4Total debt1,343.5Net cash (debt)−915.1Shareholders’ equity859.3Debt to equity1.56Fiscal year 2024Cash1,103.0Total debt1,137.1Net cash (debt)−34.1Shareholders’ equity1,527.7Debt to equity0.74Fiscal year 2025Cash801.3Total debt829.0Net cash (debt)−27.7Shareholders’ equity1,140.6Debt to equity0.73
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 122.4 599.7 370.8 835.1 1,502.6 2,115.9 966.8 428.4 1,103.0 801.3
Total debt 17.7 431.1 420.6 n/a n/a 563.7 1,544.3 1,343.5 1,137.1 829.0
Net cash (debt) 104.8 168.6 −49.7 n/a n/a 1,552.2 −577.5 −915.1 −34.1 −27.7
Shareholders’ equity 336.7 789.2 1,032.3 818.2 761.8 928.0 385.0 859.3 1,527.7 1,140.6
Debt to equity 0.05 0.55 0.41 n/a n/a 0.61 4.01 1.56 0.74 0.73

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
5.4 154.6 301.0 380.8 455.9 612.4 843.8 1,144.9 1,788.0 1,864.3
Growth +2,751.6% +94.7% +26.5% +19.7% +34.3% +37.8% +35.7% +56.2% +4.3%
n/a n/a n/a n/a n/a n/a n/a n/a n/a 25.5
188.3 166.7 401.8 n/a n/a n/a n/a n/a n/a n/a
83.7 122.7 207.8 284.8 317.9 282.7 451.4 481.9 557.9 491.7
−266.7 −171.6 −343.6 −705.6 −564.2 −459.7 −536.2 −267.8 218.1 −699.8
Growth −420.9%
−267.3 −48.6 −362.6 −713.9 −553.1 −418.9 −690.0 −520.1 260.8 −702.2
n/a 2.1 −0.7 1.2 1.1 −0.2 13.5 15.9 25.5 11.2
−267.3 −50.7 −361.9 −715.1 −554.1 −418.8 −703.5 −536.0 235.2 −713.4
Growth −403.3%
Per share
n/a n/a n/a n/a −7.11 −5.15 −8.03 −5.80 2.47 −7.13
n/a n/a n/a n/a −7.11 −5.15 −8.03 −5.80 2.34 −7.13
Growth −404.7%
48.7 58.8 66.3 73.6 78.0 81.3 87.6 92.4 95.1 100.1
n/a 58.8 66.3 73.6 78.0 81.3 87.6 92.4 107.9 100.1
Growth +12.6% +11.1% +5.9% +4.2% +7.7% +5.5% +16.8% −7.2%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 32.5% a year over five years.
  • The diluted share count rose 28.4% in five years, which is dilution.
  • Operating margin is up 86.2 points on five years ago, at -37.5%.
  • A net loss in 9 of 10 years on file.